Haemonetics Corporation (HAE) financials · rev $1.33B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Haemonetics Corporation (HAE) rev $1.33B.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $1.33B | $1.36B |
| Cost of Revenue | $546.4M | $611.9M |
| Gross Profit | $787.6M | $749.0M |
| Operating Income | $156.7M | $221.8M |
| Net Income | $97.3M | $167.7M |
| EPS (Diluted) | $2.05 | $3.31 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $2.40B | $2.45B |
| Current Assets | $834.9M | $935.0M |
| Cash & Equivalents | $245.4M | $306.8M |
| Inventory | $306.4M | $365.1M |
| PP&E | $305.8M | $284.1M |
| Total Liabilities | $1.60B | $1.63B |
| Current Liabilities | $282.6M | $578.1M |
| Short-term Debt | $5.01M | $303.6M |
| Long-term Debt | $1.22B | $921.2M |
| Total Debt | $1.22B† | $1.22B† |
| Shareholders' Equity | $796.3M | $820.8M |
| Retained Earnings | $279.3M | $352.2M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | $293.2M | $181.7M |
| CapEx | $32.8M | $39.3M |
| Investing Cash Flow | -$179.5M | -$161.9M |
| Financing Cash Flow | -$178.5M | $108.8M |
| Net Change in Cash | -$61.3M | $128.0M |
| Free Cash Flow | $260.4M | $142.4M |
FAQ
What is HAE P/E and revenue?
Haemonetics Corporation (HAE) rev $1.33B.
What is HAE revenue?
Haemonetics Corporation last cached revenue is $1.33B (FY2026).
Is HAE profitable?
Haemonetics Corporation last cached net income is $97.3M (FY2026).
What are HAE total assets?
Haemonetics Corporation last cached total assets are $2.40B (FY2026).
What is HAE free cash flow?
Haemonetics Corporation last cached free cash flow is $260.4M (FY2026).
Not investment advice. Cached statements, not a live tape.